Janux Therapeutics, Inc. (JANX)

CIK 1817713 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Janux Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005493
Aug 13, 2026SCHEDULE 13G/A0001274173-26-000200
Aug 6, 20268-K0001193125-26-337977
Aug 6, 202610-Q0001193125-26-338078
Jul 31, 202640001864158-26-000006
Jul 28, 2026SCHEDULE 13G/A0002012383-26-002544
Jul 10, 202640001864158-26-000004
Jun 23, 20268-K0001193125-26-279428
Jun 12, 202640001202785-26-000002
Jun 12, 202640001248190-26-000002
Jun 12, 202640001780547-26-000004
Jun 12, 202640001863094-26-000002
Jun 12, 20268-K0001193125-26-269387
Jun 12, 202640001231919-26-000631
Jun 12, 202640001326330-26-000002
Jun 12, 202640001666963-26-000003
Jun 4, 202640002069239-26-000005
Jun 2, 20261440002069239-26-000004
May 15, 2026SCHEDULE 13G/A0001274173-26-000148
May 13, 202640002032671-26-000004
May 12, 2026SCHEDULE 13G0000093751-26-000251
May 7, 202610-Q0001193125-26-212146
May 7, 20268-K0001193125-26-211964
May 6, 2026SCHEDULE 13G/A0000315066-26-001219
Apr 29, 2026SCHEDULE 13G0000919574-26-002474